COMPARATIVE BIOAVAILABILITY OF PREDNISOLONE METASULFOBENZOATE WITH PREDNISOLONE

被引：0

|

作者：

FLOUVAT, B

MOLINIER, P

DELLATOLAS, F

机构：

[1] THERAPHARM RECH,F-92 BOULOGNE,FRANCE

[2] LABS HOUDE,F-75 PARIS,FRANCE

来源：

THERAPIE | 1994年 / 49卷 / 01期

关键词：

D O I：

暂无

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：53 / 54

页数：2

相关论文

共 50 条

[11] OCULAR BIOAVAILABILITY OF TOPICAL PREDNISOLONE PREPARATIONS
OLEJNIK, O
WEISBECKER, CA
CLINICAL THERAPEUTICS, 1990, 12 (01) : 2 - 11
[12] RIFAMPICIN REDUCES EFFECTIVENESS AND BIOAVAILABILITY OF PREDNISOLONE
MCALLISTER, WAC
THOMPSON, PJ
ALHABET, SM
ROGERS, HJ
BRITISH MEDICAL JOURNAL, 1983, 286 (6369): : 923 - 925
[13] RELATIVE BIOAVAILABILITY OF PREDNISONE AND PREDNISOLONE IN MAN
TSE, FLS
WELLING, PG
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1979, 31 (07) : 492 - 493
[14] Diabetic control is not disturbed by an oral corticosteroid (prednisolone metasulfobenzoate) designed to treat colitis
Shah, R.
Henderson, H.
Cartwright-Taylor, L.
Gould, S. R.
GUT, 2007, 56 : A119 - A120
[15] BIOAVAILABILITY OF PREDNISOLONE DURING SIMULTANEOUS TREATMENT WITH CHOLESTYRAMINE
AUDETAT, V
BIRCHER, J
GASTROENTEROLOGY, 1976, 71 (06) : 1110 - 1110
[16] REDUCED PREDNISOLONE BIOAVAILABILITY DURING RIFAMPICIN TREATMENT
BERGREM, H
REFVEM, OK
KIDNEY INTERNATIONAL, 1983, 23 (03) : 551 - 551
[17] EFFECT OF ALUMINUM PHOSPHATE ON THE BIOAVAILABILITY OF CIMETIDINE AND PREDNISOLONE
ALBIN, H
VINCON, G
DEMOTESMAINARD, F
BEGAUD, B
BEDJAOUI, A
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 26 (02) : 271 - 273
[18] BIOAVAILABILITY AND REVERSIBLE METABOLISM OF PREDNISONE AND PREDNISOLONE IN MAN
GARG, V
JUSKO, WJ
BIOPHARMACEUTICS & DRUG DISPOSITION, 1994, 15 (02) : 163 - 172
[19] Bioavailability and pharmacokinetics of a new liquid prednisolone formulation in comparison with two commercially available liquid prednisolone products
Ahmed, M
Morrel, EM
Clemente, E
CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2001, 62 (07): : 548 - 556
[20] Acceptability and tolerance of prednisolone metasulfobenzoate in orally dispersing tablets in 2 to 12-years-old children
Rancé, F
Deslandes, B
Decosta, P
ARCHIVES DE PEDIATRIE, 2004, 11 (09): : 1127 - 1130

← 1 2 3 4 5 →